Status: Baseline only
Most Recent Data:
43.0 percent (2013-16) *
55.4 percent *
43.0 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16 *
* Age adjusted to the year 2000 standard population.